Flash Market News AI Explainer

Why Is AbbVie Stock Spiking Today? ABBV +5.15% (Jun 22) — Apogee Therapeutics Acquisition

Analysis Date: June 22, 2026. AbbVie (ABBV) shares spiked +5.15% today in a sharp rally. Here's the reason for the AbbVie share-price increase today — why is ABBV stock up today?

Ticker
ABBV
Company
AbbVie
Direction
Up
% Change
+5.15%
Date
June 22, 2026

What happened

On June 22, 2026, AbbVie (ABBV) shares rose more than 5% after the company announced plans to acquire Apogee Therapeutics in a deal worth approximately $10.9 billion.

  • Acquisition target: Apogee Therapeutics is a clinical-stage biopharmaceutical company focused on next-generation therapies for atopic dermatitis and other inflammatory conditions.
  • Strategic rationale: The deal strengthens AbbVie's immunology pipeline as the company continues to diversify revenue following biosimilar competition against its flagship drug, Humira.
  • Competitive impact: Analysts noted the acquisition has implications for Regeneron, which competes in the atopic dermatitis space with its drug Dupixent.
  • Deal size: The transaction is valued at approximately $10.9 billion, underscoring AbbVie's continued appetite for large-scale pipeline acquisitions.

This content is for educational and informational purposes only. This is not investment advice.

Sources

  1. AbbVie is set to acquire Apogee Therapeutics in a deal valued at approximately $10.9 billion.
  2. The acquisition has implications for Regeneron, which competes with Apogee in the atopic dermatitis space.

Frequently asked

Why is AbbVie stock up today?

AbbVie (ABBV) shares spiked +5.15% on June 22, 2026. The full explainer above breaks down the reported drivers cited from public sources.

Why did ABBV surge today?

According to the cited sources, the move on June 22, 2026 was driven by the catalyst summarized in the explainer. See the Sources list below for primary references.

What caused AbbVie stock to jump today?

On June 22, 2026, AbbVie (ABBV) shares rose more than 5% after the company announced plans to acquire Apogee Therapeutics in a deal worth approximately $10.9 billion.

ABBV stock news today?

AbbVie shares closed up +5.15% on June 22, 2026 — a increase of 5.15% from the prior close.

Is this investment advice?

No. Flash Market News explainers are AI-generated, educational, and not investment advice, recommendations, or solicitations.

AI-generated explainer from verified sources; not investment advice.

Recent explainers